[Resuscitation in ventricular fibrillation: what is essential?].
Prognosis of prehospital cardiac arrest due to ventricular fibrillation is dependent on the first minutes, as survival decreases by 10% for each minute by which resuscitation attempts are delayed. Thus, early defibrillation plays a key role in improving outcome of cardiac arrest victims. The effectiveness of automated external defibrillators (AEDs) in this setting has been proven by several clinical trials. There remains controversy with regard to using AEDs in the in-hospital setting, as well as the approach of "public access" defibrillation. Whereas the use of intravenous antiarrhythmic drugs, particularly amiodarone, remains controversial, new data support the use of vasopressine instead of epinephrine as vasopressor drug in cardiac arrest patients. The present review aims to focus on the above mentioned aspects as well as on the changes to the present ILCOR guidelines which have led to modification of the resuscitation guidelines of the European Resuscitation Council (ERC).
Gemeinschaftspraxis für Kardiologie Dres. Schiffmann/Klingenheben, Alfred-Bucherer-Str. 6, 53115 Bonn, Germany. Klingenheben@bonn-kardiologie.de
T
T
Klingenheben
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D016887:Cardiopulmonary Resuscitation / Q000379:methods* / Q000592:standards / Q000639:trends; D002986:Clinical Trials as Topic; D003422:Critical Care / Q000379:methods* / Q000592:standards / Q000639:trends; D004554:Electric Countershock / Q000379:methods* / Q000592:standards / Q000639:trends; D004632:Emergency Medical Services / Q000379:methods* / Q000592:standards / Q000639:trends; D005060:Europe; D006801:Humans; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000628:therapy*
D000889:Anti-Arrhythmia Agents